Wang Xiao, Gao Peng, Wang Meng, Liu Jing, Lin Jiaxiang, Zhang Shule, Zhao Yiwei, Zhang Jingwen, Pan Wei, Sun Zeyu, Sun Feifei, Zhao Weiming, Guo Chenghao, Wang Qingwei
Department of Pathology, School of Medicine, Shandong UniversityJinan 250012, PR China.
Department of Pathology, Qilu Hospital of Shandong UniversityJinan 250012, PR China.
Am J Transl Res. 2017 May 15;9(5):2327-2339. eCollection 2017.
Previously, we found that cancerous inhibitor of protein phosphatase 2A (CIP2A) plays a key role in the malignant transformation of cervical cancer. Here, we further explore whether and how CIP2A is regulated by human papillomavirus E7 (HPV E7) and the prognostic value of CIP2A in cervical cancer. We demonstrated a positive feedback loop between the E2F transcription factor 1 (E2F1) and CIP2A at the transcription level in HeLa and SiHa cells by real-time PCR and western blot analysis. The feedback, regulated by HPV E7, was further confirmed by their sub-cellular co-expression seen on immunofluorescence and immunohistochemistry staining and . Moreover, CIP2A and E2F1 expression was greatly elevated in human cervical cancer tissue. CIP2A expression was tightly associated with tumor size, depth of invasion and lymph node metastasis in 184 cases of cervical cancer. Kaplan-Meier and Cox proportional-hazards regression analyses revealed poor overall and disease-free survival of patients with CIP2A-E2F1 co-expression, and high CIP2A-E2F1 co-expression was an independent risk factor for overall survival of patients. Therefore, CIP2A-E2F1 expression might be a valuable indicator to predict outcome and guide personal treatment in cervical cancer.
此前,我们发现蛋白磷酸酶2A的癌性抑制剂(CIP2A)在宫颈癌的恶性转化中起关键作用。在此,我们进一步探讨CIP2A是否以及如何受到人乳头瘤病毒E7(HPV E7)的调控,以及CIP2A在宫颈癌中的预后价值。通过实时PCR和蛋白质印迹分析,我们在HeLa和SiHa细胞中证明了E2F转录因子1(E2F1)与CIP2A在转录水平上存在正反馈环。免疫荧光和免疫组织化学染色显示的亚细胞共表达进一步证实了由HPV E7调控的这种反馈。此外,CIP2A和E2F1在人宫颈癌组织中的表达大幅升高。在184例宫颈癌病例中,CIP2A表达与肿瘤大小、浸润深度和淋巴结转移密切相关。Kaplan-Meier和Cox比例风险回归分析显示,CIP2A-E2F1共表达的患者总生存率和无病生存率较差,且高CIP2A-E2F1共表达是患者总生存的独立危险因素。因此,CIP2A-E2F1表达可能是预测宫颈癌预后和指导个体化治疗的有价值指标。